Akanda Non-Current Deferred Revenue (Quarterly) Analysis

Akanda Corp. (AKAN)

2.57 +0.12 (+5.03%) USD | NASDAQ | Jan 12, 16:00

2.62 +0.05 (+1.95%) After-Hours: 19:07

View Non-Current Deferred Revenue (Quarterly) for AKAN.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

Alterola Biotech, Inc.	--
Kiniksa Pharmaceuticals International Plc	Upgrade
Aditxt, Inc.	--
Iovance Biotherapeutics, Inc.	--
Travere Therapeutics, Inc.	--